BioSpace News Archive

Kane Biotech Inc. announces that on August 19, 2020 it granted an aggregate of 2,310,555 stock options to certain directors, officers, employees and consultants of the Company in accordance with the Company’s stock option plan.

CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent leader in hemp-derived cannabidiol (CBD) products, today announced that Joseph Dowling, its Chief Executive Officer, will participate in a virtual ‘fireside’ chat, which is part of the series ‘The Cannabis Chronicles’ hosted by Aaron Grey, Managing Director of Consumer & Cannabis Equity Research at Alliance Global Partners, on Friday, August 21,

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that two abstracts featuring data from the Phase 3 program evaluating Sci-B-Vac®, the company’s tri-antigenic prophylactic hepatitis B (HBV) vaccine, have been accepted for presentation at The Digital International Liver Congress TM 2020 (ILC),

Metova , a leading provider of custom software solutions for mobile, web, connected home and car, and Internet of Things (IoT) for the private and public sector and Innovator Health , a leading

Pooling capability will allow more tests to be performed at a single time to meet COVID-19 testing demand, which will be a key element in supporting schools and large corporations to rapidly and efficiently test returning students and employees University of Alabama at Birmingham utilizes Ovation’s pooled COVID-19 testing CAMBRIDGE, Mass.--( BUSINESS WIRE )-- Ovation.io, Inc. (Ovation), makers of revolutionary solutions for molecular diagnos

Trellus Health, a resilience-driven digital health solution for chronic conditions, today announced that it has raised $5 million of seed funding to transform the way chronic conditions are treated, with an initial focus in Inflammatory Bowel Disease (IBD), including Crohn’s disease and ulcerative colitis.

Garwood Medical Devices, a leader in groundbreaking medical device technology, today announced a Series C financing round of $4 million to support additional preclinical testing for its BioPrax™ device. Infection is the most serious complication of joint replacement. 2.2 percent of prosthetic hip or knee replacements develop

Through its Stand Up For Clean Air initiative, American Lung Association drives science-based conversations around health impacts of climate change and air pollution to encourage action

Celularity, Inc. (“Celularity” or “the Company”) today announced that it has sold its UltraMIST® Ultrasound Healing Therapy asset to Sanuwave Health, Inc. [OTC PNK: SNWV] (“Sanuwave”) in connection with which Celularity granted Sanuwave certain partnership rights to the Company’s wound care biologic product portfolio.

CDI Laboratories, Inc. announced the addition of its SARS-CoV-2 (COVID19) assay platform. The assays use CDI’s VirScan service which can detect antibodies to 1345 individ